WHD
Cactus Inc
63.40$
+2.0%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 33.7% | 36.5% | 39.1% | 41.1% | 43.4% | 44.5% | 45.7% | 47.9% | 49.8% | 51.0% | 47.8% | 49.6% | |
| 4.4% | 8.8% | 12.3% | 15.2% | 18.0% | 19.7% | 19.7% | 22.2% | 23.9% | 26.4% | 11.9% | 14.2% | |
| 4.4% | 8.8% | 12.3% | 15.2% | 18.0% | 19.7% | 19.7% | 22.2% | 23.9% | 26.4% | 11.9% | 14.2% | |
| 14.1% | 13.5% | 13.2% | 12.6% | 11.7% | 11.0% | 12.4% | 11.4% | 10.8% | 8.8% | 18.7% | 19.7% | |
| 13.9% | 13.5% | 12.9% | 12.7% | 13.1% | 13.0% | 13.0% | 13.5% | 14.5% | 14.8% | 16.4% | 15.0% | |
| 24.9% | – | – | – | 21.9% | 21.3% | 21.0% | 20.3% | 19.7% | 19.3% | – | – | |
| 13.7% | 13.3% | 12.9% | 12.5% | 12.1% | 11.7% | 11.5% | 11.1% | 10.9% | 10.8% | 10.1% | 11.1% | |
| 12.6% | 11.8% | 11.2% | 10.6% | 10.0% | 9.4% | 9.0% | 8.6% | 8.2% | 7.9% | 14.8% | 13.5% | |
| 31.0% | 30.1% | 30.2% | 29.0% | 27.9% | 27.3% | 26.2% | 26.1% | 25.3% | 23.4% | 33.0% | 34.1% | |
| 12.1% | 11.5% | 12.1% | 11.0% | 11.4% | 10.3% | 9.4% | 9.9% | 9.4% | 8.8% | 18.4% | 19.2% | |
| 0.8% | 0.8% | 0.7% | 0.7% | 0.7% | 0.6% | 0.7% | 0.7% | 0.7% | 0.7% | 0.6% | 0.7% | |
| 4.5% | 4.7% | 4.2% | 3.9% | 4.5% | 4.1% | 3.6% | 4.6% | 3.6% | 3.8% | 12.8% | 12.4% | |
| 56.1% | 56.8% | 56.7% | 58.7% | 59.6% | 61.6% | 62.6% | 62.9% | 63.8% | 65.5% | 48.4% | 48.0% | |
| 24.6% | 26.3% | 27.4% | 29.1% | 30.6% | 31.7% | 33.2% | 33.9% | 34.9% | 36.4% | 25.3% | 25.6% | |
| 4.5% | 5.2% | 5.0% | 4.1% | 4.8% | 4.6% | 3.9% | 3.8% | 3.7% | 3.7% | 2.8% | 2.7% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.